This article is more than 5 years old. Information may no longer be current.

Jakemans announces US launch of its Gopo supplement

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Jakemans Inc., a subsidiary of G.R. Lane Health Products Ltd, announced its Gopo Rosehip with Galactolipids will be available in the United States as of spring 2016, according to a press release.

According to the company, the plant-derived supplement has been shown in studies to provide relief to patients with rheumatoid arthritis and osteoarthritis (OA).

“Gopo has been helping joint pain sufferers in other countries for many years,” Jonathan Groves, president at Jakemans Inc., said in the release. “While the number of people experiencing joint problems is increasing, few newer or more effective solutions have been available to them, until now. We are excited to introduce this product to the U.S. market so that people experiencing joint problems — from senior citizens to elite athletes — can care for their joints and continue to enjoy an active lifestyle.”

Reference:

www.gopo.us.com